Chanza, N. M., Soukane, L., Barthelemy, P., Carnot, A., Gil, T., Casert, V., . . . Awada, A. (2021). Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: A multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial). BMC.
Cita Chicago Style (17a ed.)Chanza, Nieves Martinez, et al. Avelumab as Neoadjuvant Therapy in Patients with Urothelial Non-metastatic Muscle Invasive Bladder Cancer: A Multicenter, Randomized, Non-comparative, Phase II Study (Oncodistinct 004 - AURA Trial). BMC, 2021.
Cita MLA (8a ed.)Chanza, Nieves Martinez, et al. Avelumab as Neoadjuvant Therapy in Patients with Urothelial Non-metastatic Muscle Invasive Bladder Cancer: A Multicenter, Randomized, Non-comparative, Phase II Study (Oncodistinct 004 - AURA Trial). BMC, 2021.